India's DCGI Halts Avandia's TIDE Trial Aimed At Proving CV Safety; Steps Up Review of "Controversial Drugs" Sold In India

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.